How AI Is Mitigating Threats In Capital Markets
Public companies now face threats they couldn't have imagined a decade ago. But AI is helping them fight back hard.
Hosted on MSN49m
Lilly's Zepbound approved by FDA for sleep apnea treatment
The FDA has approved Lilly's Zepbound, a glp-1 agonist, for the treatment of sleep apnea, which affects 25 million Americans ...